Hap Trading, LLC Insmed Inc Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	SELL	$62.0 - $79.01 $32.2 Million - $41 Million	-518,800 Reduced 95.84%	22,500 $139 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $11.9 Million - $37.7 Million	541,300 New	541,300 $10.6 Billion
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $221,328 - $299,026	10,600 New	10,600 $9,000
Q2 2020 Aug 10, 2020	SELL	$14.11 - $29.42 $156,621 - $326,562	-11,100 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$13.63 - $33.98 $151,293 - $377,177	11,100 New	11,100 $4,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.